跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,708 条关于
“Sagard Healthcare Royalty Partners”
全部
15,708
临床试验
3,269
药物
126
机构
587
资讯
11,726
10个月前
GSK and AnaptysBio File Dueling Lawsuits Over Jemperli Royalty Agreement as Cancer Drug Nears Blockbuster Status
去年
Nuvation Bio Secures $250M Financing Package to Launch Novel Lung Cancer Drug Taletrectinib
4个月前
HealthCare Royalty Secures Modeyso Royalty Rights Following Strong Early Commercial Performance
去年
MacroGenics Secures $70 Million in ZYNYZ Royalty Deal, Extends Cash Runway Through 2027
去年
Heidelberg Pharma Secures $20 Million in Amended Royalty Deal with HealthCare Royalty for Renal Cancer Diagnostic
11个月前
AnaptysBio Plans Corporate Split to Separate Royalty Assets from Drug Development Operations
3个月前
Royalty Pharma to Present at Goldman Sachs 47th Annual Global Healthcare Conference
去年
DRI Healthcare Trust Acquires Royalty Interest in KalVista's Seb способов лечения Hereditary Angioedema Drug
6个月前
Heidelberg Pharma Secures $45 Million Through Modified Licensing Agreement with HealthCare Royalty and Soleus Capital
去年
Royalty Pharma Acquires $950 Million IMDELLTRA Royalty Rights from BeOne Medicines
第 1 页，共 1173 页
上一页
下一页
